Sutro Biopharma makes three appointments
This article was originally published in Scrip
Executive Summary
Sutro Biopharma (US) has announced three new appointments: Henry Heinsohn, former senior scientist in process development at Genentech, as vice-president of development and manufacturing; Dr Lesley Stolz, former vice-president of corporate and business development at Sunesis Pharmaceuticals, as vice-president of business development; and Daniel Petree of P2 Partners as a member of the board of directors.